BBa_K142011

BBa_K142011 Version 1

Component

Source:
http://parts.igem.org/Part:BBa_K142011
Generated By: https://synbiohub.org/public/igem/igem2sbol/1
Created by: Julius Rabl
Date created: 2008-10-28 12:00:00
Date modified: 2015-05-08 01:10:22

lacI IS mutant T276Fwith RBS and terminator



Types
DnaRegion

Roles
engineered_region

Generator

Sequences BBa_K142011_sequence (Version 1)

Description

lacI IS mutant (IPTG unresponsive) with ribosome binding site and terminator



Short description:


The lacI IS mutant is almost identical to the lacI transcriptional regulator except for the difference that it is not able to bind IPTG or allolactose due to a mutation; it therefore can not be activated by induction with these substances. Since it recognizes the same motif in the lac promotor region, it strongly represses transcription of all genes regulated by promotors with lacI binding site even if IPTG or allolactose are present. It can be used to terminate the expression of proteins under lac control if IPTG can not be removed from the cell rapidly.

Detailed description:


Expression of the lac operon in E. coli is tightly controlled by lacI, a protein, which binds to a repressor binding site within the promotor and disables transcription by obscuring the promotor region. When bound to DNA, lacI is in the tetrameric form, which consists of two dimers interacting at the end distal from the DNA binding site. Upon binding of allolactose or IPTG, the tetramer breaks down into two dimers and the affinity for the repressor binding site is greatly reduced; the lacI IPTG complex will diffuse away from the repressor binding site, leaving the promotor accessible. As a result of decades of genetic and structural studies, the function of lacI is now understood on the molecular level (1, 2). Mutational experiments have identified residues, which abolish IPTG response upon mutation (3). Furthermore, the x-ray crystal structure of lacI with bound IPTG has allowed the identification of residues that interact with IPTG and which are promising targets for mutagenesis (1).

[[image:jr_pulsegen_1.jpg|frame|none|
Figure 3: A Lac repressor tetramer, residues R197 and T276 are shown in red. B IPTG bound to the inducer binding site of the lac repressor, residues R197 and T276 are shown in green. Molecular graphics was generated from coordinate set 1lbh (1) using UCSF Chimera.]]


We decided to mutate residues R197 and T276, which are located in the IPTG binding groove, contact IPTG and have been shown to produce the lacI IS mutation in previous genetic experiments. Since a quantitative study of the strength of inhibition by different lacI IS mutants has to our knowledge not been published so far, we decided to generate a set of eight mutated lacIs, in which we replaced either R197 with alanine or phenylalanine or T276 with alanine or phenylalanine or both in all possible combinations.

lacIIS-1: R197A

lacIIS-2: R197F

lacIIS-3: T276A

lacIIS-4: T276F

lacIIS-5: R197A T276A

lacIIS-6: R197A T276F

lacIIS-7: R197F T276A

lacIIS-8: R197F T276F

This BioBrick is based on BioBrick I763026 and contains a ribosome binding site, the lacI IS gene and a double terminator. As sequencing by Caltech has shown that BioBrick I763026 did not have a promotor this BioBrick is promotorless, too. Expression of the mutant LacI IS (and silencing of lac-controlled gene expression) can therefore be controlled by any promotor of choice if this BioBrick is cloned behind it.

References:



(1) Lewis, M., Chang, G., Horton, N. C., Kercher, M. A., Pace, H. C., Schumacher, M. A., Brennan, R. G., and Lu, P. (1996) Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science 271, 1247-54.

(2) Friedman, A. M., Fischmann, T. O., and Steitz, T. A. (1995) Crystal structure of lac repressor core tetramer and its implications for DNA looping. Science 268, 1721-7.

(3) Suckow, J., Markiewicz, P., Kleina, L. G., Miller, J., Kisters-Woike, B., and Muller-Hill, B. (1996) Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol 261, 509-23.

Notes

During site-directed mutagenesis, the codons to be mutated were replaced with the most highly utilized codons in E. coli to prevent complications from the use of rare codons. The lacI IS sequences were analyzed for BioBrick restriction sites within the coding sequence to ensure their compatibility.

Source

The lacI IS mutant presented derive from the BioBrick I763026, which as it turned out during sequencing by the Caltech team, did not have a promotor. Site-directed mutagenesis was performed by PCR, subsequent DpnI digest and transformation. The following primers were used for mutagenesis:

R197F forward

CGGCGCGTCTGTTTCTGGCTGGCTG

R197A forward

CGGCGCGTCTGGCGCTGGCTGGCTG

R197F reverse

CAGCCAGCCAGAAACAGACGCGCCG

R197A reverse

CAGCCAGCCAGCGCCAGACGCGCCG



T276F forward

GGATACGACGATTTTGAAGACAGCTC

T276A forward

GGATACGACGATGCGGAAGACAGCTC

T276F reverse

GAGCTGTCTTCAAAATCGTCGTATCC

T276A reverse

GAGCTGTCTTCCGCATCGTCGTATCC

igem#sampleStatus
It's complicated
igem#status
Planning
 
synbiohub#ownedBy
user/james
 
synbiohub#ownedBy
user/myers
 
synbiohub#topLevel
BBa_K142011/1